Guardant Health Inc.
09/24/2025 | Press release | Distributed by Public on 09/24/2025 05:51
Regulation FD Disclosure (Form 8-K)
Item 7.01 Regulation FD Disclosure.
Guardant Health, Inc. (the "Company") will host an Investor Day on September 24, 2025 beginning at 9:00 a.m. Eastern time in New York City. The presentation will include remarks from Helmy Eltoukhy and AmirAli Talasaz, co-Chief Executive Officers, and other members of the executive management team, to highlight the Company's operations and to provide updates to the Company's key strategic priorities and financial outlook.
All interested parties may access the live and archived webcast of the presentation on the "Investors" section of the Company's website at: www.guardanthealth.com.
The information in this Current Report on Form 8-K is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Guardant Health Inc. published this content on September 24, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 24, 2025 at 11:51 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]